Portal de Periódicos da CAPES

Major Adverse Cardiovascular Events After 12 Months Among Patients With Acute Coronary Syndrome Receiving Loading Doses of Atorvastatin Prior to Planned PCI

2020; American Medical Association; Volume: 323; Issue: 8 Linguagem: Inglês

10.1001/jama.2020.0118

1538-3598

Renato D. Lópes, Pedro Gabriel Melo de Barros e Silva, Lucas Petri Damiani, Renato Hideo Nakagawa Santos, John H. Alexander, Christopher B. Granger, Otávio Berwanger,

Cardiac Imaging and Diagnostics

This study uses SECURE-PCI trial data to compare the effects of periprocedural loading doses of atorvastatin vs placebo on major adverse cardiac events (MACE) 12 months after randomization in patients with acute coronary syndrome (ACS) and planned invasive management.